1
|
von Rüden EL, Janssen-Peters H, Reiber M, van Dijk RM, Xiao K, Seiffert I, Koska I, Hubl C, Thum T, Potschka H. An exploratory approach to identify microRNAs as circulatory biomarker candidates for epilepsy-associated psychiatric comorbidities in an electrical post-status epilepticus model. Sci Rep 2023; 13:4552. [PMID: 36941269 PMCID: PMC10027890 DOI: 10.1038/s41598-023-31017-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Accepted: 03/06/2023] [Indexed: 03/23/2023] Open
Abstract
Patients with epilepsy have a high risk of developing psychiatric comorbidities, and there is a particular need for early detection of these comorbidities. Here, in an exploratory, hypothesis-generating approach, we aimed to identify microRNAs as potential circulatory biomarkers for epilepsy-associated psychiatric comorbidities across different rat models of epilepsy. The identification of distress-associated biomarkers can also contribute to animal welfare assessment. MicroRNA expression profiles were analyzed in blood samples from the electrical post-status epilepticus (SE) model. Preselected microRNAs were correlated with behavioral and biochemical parameters in the electrical post-SE model, followed by quantitative real-time PCR validation in three additional well-described rat models of epilepsy. Six microRNAs (miR-376a, miR-429, miR-494, miR-697, miR-763, miR-1903) were identified showing a positive correlation with weight gain in the early post-insult phase as well as a negative correlation with social interaction, saccharin preference, and plasma BDNF. Real-time PCR validation confirmed miR-203, miR-429, and miR-712 as differentially expressed with miR-429 being upregulated across epilepsy models. While readouts from the electrical post-SE model suggest different microRNA candidates for psychiatric comorbidities, cross-model analysis argues against generalizability across models. Thus, further research is necessary to compare the predictive validity of rodent epilepsy models for detection and management of psychiatric comorbidities.
Collapse
Affiliation(s)
- Eva-Lotta von Rüden
- Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University (LMU) Munich, Koeniginstr. 16, 80539, Munich, Germany
| | - Heike Janssen-Peters
- Hannover Medical School (MHH), Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover, Germany
| | - Maria Reiber
- Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University (LMU) Munich, Koeniginstr. 16, 80539, Munich, Germany
| | - Roelof Maarten van Dijk
- Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University (LMU) Munich, Koeniginstr. 16, 80539, Munich, Germany
| | - Ke Xiao
- Hannover Medical School (MHH), Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover, Germany
| | - Isabel Seiffert
- Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University (LMU) Munich, Koeniginstr. 16, 80539, Munich, Germany
| | - Ines Koska
- Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University (LMU) Munich, Koeniginstr. 16, 80539, Munich, Germany
| | - Christina Hubl
- Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University (LMU) Munich, Koeniginstr. 16, 80539, Munich, Germany
| | - Thomas Thum
- Hannover Medical School (MHH), Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover, Germany
| | - Heidrun Potschka
- Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University (LMU) Munich, Koeniginstr. 16, 80539, Munich, Germany.
| |
Collapse
|
2
|
Fujimori A, Hirakawa H, Liu C, Akiyama T, Engelward BP, Nickoloff JA, Suzuki M, Wang B, Nenoi M, Sai S. Recombinant cell-detecting RaDR-GFP in mice reveals an association between genomic instability and radiation-induced-thymic lymphoma. Am J Cancer Res 2022; 12:562-573. [PMID: 35261787 PMCID: PMC8899999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2021] [Accepted: 12/27/2021] [Indexed: 06/14/2023] Open
Abstract
In this study, we aimed to investigate how homologous recombinant (HR)-related genomic instability is involved in ionizing radiation (IR)-induced thymic lymphoma in mice. We divided five-week-old Rosa26 Direct Repeat-GFP (RaDR-GFP) transgenic mice into non-IR control and IR groups and exposed the mice in the IR group to a 7.2 Gy dose of γ-rays, delivered in 1.8 Gy fractions, once a week for four weeks. We then estimated mouse survival and recorded their body, thymus, and spleen weights. The frequency of HR events in the chromosomes of the thymus, bone marrow, and spleen cells and the phenotype of thymic lymphoma cells were analyzed using fluorescence-activated cell sorting (FACS). We found that most mice in the IR group developed thymic lymphoma, their survival rate decreasing to 20% after 180 days of IR exposure, whereas no mice died in the non-IR control group until day 400. The thymus and spleen weighed significantly more in the IR-4-month group than that in the non-IR group; however, we observed no significant differences between the body weights of the control and IR mice. FACS analysis indicated that the frequency of HR events significantly increased at two and four months after the last IR dose in the bone marrow and thymus cells, but not in the spleen cells of RaDR-GFP transgenic mice, suggesting that recombinant cells accumulated in the thymus upon IR exposure. This suggests that IR induces genome instability, revealed as increased HR, that drives the development of thymic lymphoma. Additionally, phenotypic analysis of lymphoma cells showed an increase in the CD4-/CD8+ (CD8SP) cell population and a decrease in the CD4+/CD8- (CD4SP) cell population in the IR-4-month group compared to that in the non-IR group, indicating that IR induces an aberrant cell phenotype characteristic of lymphoma. In conclusion, we observed a significant increase in HR events and abnormal phenotype in thymic lymphoma cells at two and four months after IR exposure in both the thymus and bone marrow tissues, suggesting that genomic instability is involved in the early stages of thymic lymphomagenesis. Our study indicates that HR-visualizing RaDR-GFP transgenic mice can help explore the links between the molecular mechanisms of genome instability and IR-induced tumorigenesis.
Collapse
Affiliation(s)
- Akira Fujimori
- Department of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST)Chiba 263-8555, Japan
| | - Hirokazu Hirakawa
- Department of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST)Chiba 263-8555, Japan
| | - Cuihua Liu
- Department of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST)Chiba 263-8555, Japan
| | - Taishin Akiyama
- Laboratory for Immune Homeostasis, RIKEN Center for Integrative Medical SciencesYokohama 230-0045, Japan
| | - Bevin P Engelward
- Department of Biological Engineering, Massachusetts Institute of TechnologyCambridge, MA 02139, USA
| | - Jac A Nickoloff
- Department of Environmental and Radiological Health Sciences, Colorado State UniversityFort Collins, CO 80523, USA
| | - Masao Suzuki
- Department of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST)Chiba 263-8555, Japan
| | - Bing Wang
- Department of Radiation Effects Research, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST)Chiba 263-8555, Japan
| | - Mitsuru Nenoi
- Human Resources Development Center, National Institutes for Quantum Science and TechnologyChiba 263-8555, Japan
| | - Sei Sai
- Department of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST)Chiba 263-8555, Japan
| |
Collapse
|
3
|
Liu C, Hirakawa H, Katsube T, Fang Y, Tanaka K, Nenoi M, Fujimori A, Wang B. Altered Induction of Reactive Oxygen Species by X-rays in Hematopoietic Cells of C57BL/6-Tg (CAG-EGFP) Mice. Int J Mol Sci 2021; 22:6929. [PMID: 34203224 PMCID: PMC8268547 DOI: 10.3390/ijms22136929] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Revised: 06/14/2021] [Accepted: 06/15/2021] [Indexed: 12/20/2022] Open
Abstract
Previous work pointed to a critical role of excessive production of reactive oxygen species (ROS) in increased radiation hematopoietic death in GFP mice. Meanwhile, enhanced antioxidant capability was not demonstrated in the mouse model of radio-induced adaptive response (RAR) using rescue of radiation hematopoietic death as the endpoint. ROS induction by ex vivo X-irradiation at a dose ranging from 0.1 to 7.5 Gy in the nucleated bone marrow cells was comparatively studied using GFP and wild type (WT) mice. ROS induction was also investigated in the cells collected from mice receiving a priming dose (0.5 Gy) efficient for RAR induction in WT mice. Significantly elevated background and increased induction of ROS in the cells from GFP mice were observed compared to those from WT mice. Markedly lower background and decreased induction of ROS were observed in the cells collected from WT mice but not GFP mice, both receiving the priming dose. GFP overexpression could alter background and induction of ROS by X-irradiation in hematopoietic cells. The results provide a reasonable explanation to the previous study on the fate of cells and mice after X-irradiation and confirm enhanced antioxidant capability in RAR. Investigations involving GFP overexpression should be carefully interpreted.
Collapse
Affiliation(s)
- Cuihua Liu
- Molecular and Cellular Radiation Biology Group, Department of Charged Particle Therapy Research, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; (C.L.); (H.H.); (Y.F.)
| | - Hirokazu Hirakawa
- Molecular and Cellular Radiation Biology Group, Department of Charged Particle Therapy Research, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; (C.L.); (H.H.); (Y.F.)
| | - Takanori Katsube
- Dietary Effects Research Group, Department of Radiation Effects Research, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; (T.K.); (K.T.)
| | - Yaqun Fang
- Molecular and Cellular Radiation Biology Group, Department of Charged Particle Therapy Research, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; (C.L.); (H.H.); (Y.F.)
| | - Kaoru Tanaka
- Dietary Effects Research Group, Department of Radiation Effects Research, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; (T.K.); (K.T.)
| | - Mitsuru Nenoi
- Human Resources Development Center, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan;
| | - Akira Fujimori
- Molecular and Cellular Radiation Biology Group, Department of Charged Particle Therapy Research, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; (C.L.); (H.H.); (Y.F.)
| | - Bing Wang
- Dietary Effects Research Group, Department of Radiation Effects Research, National Institute of Radiological Sciences, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; (T.K.); (K.T.)
| |
Collapse
|
4
|
Udho EB, Huebner SM, Albrecht DM, Matkowskyj KA, Clipson L, Hedican CA, Koth R, Snow SM, Eberhardt EL, Miller D, Van Doorn R, Gjyzeli G, Spengler EK, Storts DR, Thamm DH, Edmondson EF, Weil MM, Halberg RB, Bacher JW. Tumor aggressiveness is independent of radiation quality in murine hepatocellular carcinoma and mammary tumor models. Int J Radiat Biol 2021; 97:1140-1151. [PMID: 33720813 DOI: 10.1080/09553002.2021.1900946] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
PURPOSE Estimating cancer risk associated with interplanetary space travel is complicated. Human exposure data to high atomic number, high-energy (HZE) radiation is lacking, so data from low linear energy transfer (low-LET) γ-ray radiation is used in risk models, with the assumption that HZE and γ-ray radiation have comparable biological effects. This assumption has been challenged by reports indicating that HZE radiation might produce more aggressive tumors. The goal of this research is to test whether high-LET HZE radiation induced tumors are more aggressive. MATERIALS AND METHODS Murine models of mammary and liver cancer were used to compare the impact of exposure to 0.2Gy of 300MeV/n silicon ions, 3 Gy of γ-rays or no radiation. Numerous measures of tumor aggressiveness were assessed. RESULTS For the mammary cancer models, there was no significant change in the tumor latency or metastasis in silicon-irradiated mice compared to controls. For the liver cancer models, we observed an increase in tumor incidence but not tumor aggressiveness in irradiated mice. CONCLUSION Tumors in the HZE-irradiated mice were not more aggressive than those arising from exposure to low-LET γ-rays or spontaneously. Thus, enhanced aggressiveness does not appear to be a uniform characteristic of all tumors in HZE-irradiated animals.
Collapse
Affiliation(s)
| | - Shane M Huebner
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA
| | - Dawn M Albrecht
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA
| | - Kristina A Matkowskyj
- Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.,Department of Pathology & Laboratory Medicine, University of Wisconsin, Madison, WI, USA.,William S. Middleton VA Medical Center, Madison, WI, USA
| | - Linda Clipson
- Department of Oncology, University of Wisconsin, Madison, WI, USA
| | | | | | - Santina M Snow
- Department of Oncology, University of Wisconsin, Madison, WI, USA
| | - Emily L Eberhardt
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA
| | - Devon Miller
- Promega Corporation, Madison, WI, USA.,Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA
| | - Rachel Van Doorn
- Promega Corporation, Madison, WI, USA.,Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA
| | - Genti Gjyzeli
- Promega Corporation, Madison, WI, USA.,Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA
| | - Erin K Spengler
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA
| | | | - Douglas H Thamm
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA
| | - Elijah F Edmondson
- Molecular Histopathology Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Michael M Weil
- Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA
| | - Richard B Halberg
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA.,Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.,Department of Oncology, University of Wisconsin, Madison, WI, USA
| | - Jeffery W Bacher
- Promega Corporation, Madison, WI, USA.,Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin, Madison, WI, USA
| |
Collapse
|